Your browser doesn't support javascript.
loading
Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang, Mei-Chi; Chang, Hsiao-Hua; Wang, Tong-Mei; Chan, Chiu-Po; Lin, Bor-Ru; Yeung, Sin-Yuet; Yeh, Chien-Yang; Cheng, Ru-Hsiu; Jeng, Jiiang-Huei.
Affiliation
  • Chang MC; Biomedical Science Team, Chang Gung University of Science and Technology, Taoyuan,Taiwan.
  • Chang HH; Laboratory of Pharmacology & Toxicology, Graduate Institute of Clinical Dentistry and Department of Dentistry, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan.
  • Wang TM; Laboratory of Pharmacology & Toxicology, Graduate Institute of Clinical Dentistry and Department of Dentistry, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan.
  • Chan CP; Department of Dentistry, Chang Gung Memorial Hospital and Chang Gung University, Taipei, Taiwan.
  • Lin BR; Department of Diagnotherapeutics, National Taiwan University Hospital, Taipei, Taiwan.
  • Yeung SY; Department of Dentistry, Chang Gung Memorial Hospital and Chang Gung University, Taipei, Taiwan.
  • Yeh CY; Laboratory of Pharmacology & Toxicology, Graduate Institute of Clinical Dentistry and Department of Dentistry, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan.
  • Cheng RH; Biomedical Science Team, Chang Gung University of Science and Technology, Taoyuan,Taiwan.
  • Jeng JH; Laboratory of Pharmacology & Toxicology, Graduate Institute of Clinical Dentistry and Department of Dentistry, National Taiwan University Hospital and National Taiwan University Medical College, Taipei, Taiwan.
PLoS One ; 9(8): e104310, 2014.
Article in En | MEDLINE | ID: mdl-25122505
Catechol (benzenediol) is present in plant-derived products, such as vegetables, fruits, coffee, tea, wine, areca nut and cigarette smoke. Because platelet dysfunction is a risk factor of cardiovascular diseases, including stroke, atherosclerosis and myocardial infarction, the purpose of this study was to evaluate the anti-platelet and anti-inflammatory effect of catechol and its mechanisms. The effects of catechol on cyclooxygenase (COX) activity, arachidonic acid (AA)-induced aggregation, thromboxane B2 (TXB2) production, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) production and extracellular signal-regulated kinase (ERK)/p38 phosphorylation were determined in rabbit platelets. In addition, its effect on IL-1ß-induced prostaglandin E2 (PGE2) production by fibroblasts was determined. The ex vivo effect of catechol on platelet aggregation was also measured. Catechol (5-25 µM) suppressed AA-induced platelet aggregation and inhibited TXB2 production at concentrations of 0.5-5 µM; however, it showed little cytotoxicity and did not alter U46619-induced platelet aggregation. Catechol (10-50 µM) suppressed COX-1 activity by 29-44% and COX-2 activity by 29-50%. It also inhibited IL-1ß-induced PGE2 production, but not COX-2 expression of fibroblasts. Moreover, catechol (1-10 µM) attenuated AA-induced ROS production in platelets and phorbol myristate acetate (PMA)-induced ROS production in human polymorphonuclear leukocytes. Exposure of platelets to catechol decreased AA-induced ERK and p38 phosphorylation. Finally, intravenous administration of catechol (2.5-5 µmole/mouse) attenuated ex vivo AA-induced platelet aggregation. These results suggest that catechol exhibited anti-platelet and anti-inflammatory effects, which were mediated by inhibition of COX, ROS and TXA2 production as well as ERK/p38 phosphorylation. The anti-platelet effect of catechol was confirmed by ex vivo analysis. Exposure to catechol may affect platelet function and thus cardiovascular health.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboxane A2 / Platelet Aggregation Inhibitors / Catechols / Cyclooxygenase Inhibitors / Reactive Oxygen Species / MAP Kinase Signaling System / P38 Mitogen-Activated Protein Kinases Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Type: Article Affiliation country: Taiwan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboxane A2 / Platelet Aggregation Inhibitors / Catechols / Cyclooxygenase Inhibitors / Reactive Oxygen Species / MAP Kinase Signaling System / P38 Mitogen-Activated Protein Kinases Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Type: Article Affiliation country: Taiwan